VOLITIONRX LTD VNRX Cash Flow

Volitionrx ltd (VNRX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating Activities
Net Loss
-17,754	-16,099	-16,829	-17,125	-17,559	-18,008	-17,784	-17,200	-16,070	-14,769	-13,690	-13,276	-12,763	-11,905	-11,607	-11,091	-10,012	-9,530	-7,785	-10,716	-8,029	-8,213	-8,101	-3,132	-4,996	-3,710	-4,358	-4,305	-4,189	-4,083	0	0	0	-	-	-	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
689	676	722	684	647	636	631	620	591	528	450	383	330	309	302	296	268	236	206	170	151	142	137	137	140	146	141	138	139	135	144	140	127	118	0	0	0
Amortization of operating lease right-of-use assets
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment
-	-	-	-	-	-	-	-	-	38	11	5	5	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangible asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Stock based compensation
1,285	1,458	1,778	1,897	2,013	2,570	0	0	0	-	-	-	2,110	1,678	1,619	1,641	1,349	1,493	1,435	1,113	1,018	767	356	200	243	282	650	683	735	858	0	0	0	-	-	-	-
Loss on warrant re-measurement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants issued for services
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	708	527	304	510	472	493	391	515	432	286	308	362	362	0	0	0
Shares issued for Director compensation in Volition Germany
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants issued for services
-	-	-	-	-	-	22	30	46	54	96	305	245	164	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing costs for warrants modified
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Amortization of stock issued in advance of services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	250	70	70	70	70	81	64	46	29	0	0	0
Non-operating income grants received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-143	-1,009	-1,009	-1,009	-865	0	0	0	-	-	-	-	-	-	-	-
Gain on derivative re-measurement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-339	-2,278	1,851	-15	1,424	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Derivative expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Prepaid expenses
-94	-22	51	-110	-210	10	-211	-125	-97	-82	-53	-87	-88	-13	73	49	-24	-12	-137	-151	-188	-78	-194	-70	63	-50	139	-50	-88	-25	-83	-1	-32	0	0	0	0
Accounts receivable
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0
Other current assets
-130	-92	-187	195	107	-29	182	-227	-166	-7	26	76	-14	-22	-48	-106	-93	-108	-32	-56	-32	-24	-75	-32	-11	5	-4	-3	0	-7	62	29	12	-14	0	0	0
Accounts payable and accrued liabilities
1,691	1,105	573	-367	-66	100	-342	1,113	-65	-339	482	627	970	1,090	878	404	271	-95	-57	313	144	281	439	-17	-129	34	195	346	494	305	93	88	101	53	0	0	0
Management and directors' fees payable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-of-use assets operating leases liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Related party payables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net Cash Used In Operating Activities
-13,887	-12,739	-13,770	-14,665	-14,877	-14,733	-14,990	-13,200	-13,029	-12,193	-10,498	-9,789	-9,373	-8,864	-8,738	-8,966	-8,501	-8,546	-7,473	-5,994	-5,369	-4,140	-3,857	-3,821	-3,505	-3,084	-2,822	-2,717	-2,306	-2,314	-2,440	-2,162	-1,878	-1,652	0	0	0
Investing Activities:
Purchases of patents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
-729	-511	-477	-413	-474	-301	-98	64	610	1,425	1,665	1,581	1,289	415	98	83	58	77	73	318	303	302	297	46	18	0	19	20	53	90	130	110	72	34	0	0	0
Purchase of patents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Used In Investing Activities
-729	-511	-477	-413	-353	-301	-268	-315	-610	-1,425	-1,665	-1,581	-1,289	-415	-98	-83	-58	-132	-128	-373	-358	-302	-297	-46	-18	-0	-19	-20	-53	-90	-81	-101	-72	-34	0	0	0
Financing Activities:
Net proceeds from issuances of common shares
-	16,591	16,937	21,109	16,110	17,245	16,796	7,915	8,751	998	12,794	12,867	12,088	25,302	14,667	14,557	14,551	12,497	12,069	13,759	14,062	5,626	5,850	4,527	5,000	2,828	2,496	2,710	2,693	2,576	1,951	2,541	1,845	1,595	0	0	0
Common stock repurchased
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on long-term debt
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from grants repayable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from grants received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	143	358	446	963	819	0	0	0	-	-	-	-	-	-	-	-
Payments on long-term debt
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on finance lease obligations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grants received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Grants received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from debt payable
-	-	-	-	-	-	-	-	-	-	-	1,139	762	474	0	0	0	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Payments on debt payable
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on finance lease obligations
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on financing leases
-	-	-	-	-	-	-	-	-	135	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-76	-258	-237	-216	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	102	545	448	348	289	0	0	0
Repayment of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Cash acquired through reverse merger
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	-	-	-	-
Cash acquired through reverse merger
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net Cash (Used In) Provided By Financing Activities
10,157	16,929	17,028	21,498	16,812	17,967	17,556	8,747	9,390	1,966	13,524	13,370	12,252	25,188	14,555	14,288	14,475	12,442	12,028	13,889	14,029	5,737	6,122	4,920	5,910	3,593	2,997	3,123	2,589	2,473	1,918	2,410	1,614	1,982	0	0	0
Effect of foreign exchange on cash
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Change in Cash
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and cash equivalents - Beginning of Period
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and cash equivalents - End of Period
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of foreign exchange on cash and cash equivalents
-	-	-	-	-	378	235	157	37	89	-47	5	-124	-145	-41	-48	61	13	5	-19	-71	-43	-21	5	2	3	2	-21	-35	-40	-39	-32	-10	4	0	0	0
Net Change in Cash and Cash Equivalents
-	-	-	-	-	3,310	2,533	-4,611	-4,212	-11,562	1,313	2,004	1,465	15,762	5,676	5,190	5,976	3,777	4,431	7,501	8,230	1,250	1,946	1,057	2,389	512	158	364	193	28	-643	113	-347	300	0	0	0
Supplemental Disclosures of Cash Flow Information:
Interest paid
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
0	-	-	-	0	-	-	-	-	-	-	-	30	20	11	14	9	7	5	10	10	10	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-Cash Financing Activities:
Common Stock issued on cashless exercises of stock options
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax paid
-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non - Cash Financing Activities:
Reduction in derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,237	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of subsidiary for debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Common stock issued for debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-18	0	-129	0	18	0	0	0	0	-	-	-	-
Shares issuable for acquisition of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Common stock issued on cashless exercises of stock options
-	-	-	-	-	-	-	-	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital lease obligation for equipment purchases
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-